Patent details

Basic Information

Publication number:

EP3791895

PCT Application Number:

CN2019086388

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP198002545

PCT Publication Number:

WO2019214707

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

PREPARATIONS COMPRISING ANTI-PCSK9 ANTIBODIES AND USE THEREOF

French Title of Invention:

PRÉPARATIONS COMPRENANT DES ANTICORPS ANTI-PCSK9 ET LEUR UTILISATION

German Title of Invention:

ZUBEREITUNGEN MIT ANTI-PCSK9-ANTIKÖRPERN UND IHRE VERWENDUNG

SPC Number:

Dates

Filing date:

10/05/2019

Grant date:

30/10/2024

EP Publication Date:

17/03/2021

PCT Publication Date:

14/11/2019

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/10/2024

EP B1 Publication Date:

30/10/2024

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

10/05/2039

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

23/10/2024

 

 

Name:

Innovent Biologics (Suzhou) Co., Ltd.

Address:

168 Dongping Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, China (CN)

Inventor

1

Name:

LIU, Xiaolin

Address:

China (CN)

2

Name:

WANG, Yinjue

Address:

China (CN)

3

Name:

XIE, Ruixia

Address:

China (CN)

Priority

Priority Number:

201810450088

Priority Date:

11/05/2018

Priority Country:

China (CN)

Classification

IPC classification:

A61K 39/395; A61P 3/06; A61P 5/00;

Publication

European Patent Bulletin

Issue number:

202444

Publication date:

30/10/2024

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

02/06/2025

Annual Fee Number:

7

Annual Fee Amount:

82 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages